Earnings History Data for Emergent Biosolutions, Inc. (EBS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
29-07-2021	AH	4:05 PM ET (Jul 29)	EBS	Emergent Biosolutions, Inc.	3,360	0.33	1.81	1.98	Emergent Biosolutions EPS misses by $1.23, misses on revenue [7/29/2021 4:17 PM]	65.97	0.75 (1.15%)	62.00	-3.22 (-4.94%)	55.07 - 137.61	715,321	490,000	3,297
Emergent to restart COVID-19 vaccine production at Baltimore Plant [7/29/2021 6:46 AM] Emergent Biosolutions EPS misses by $1.23, misses on revenue [7/29/2021 4:17 PM] Emergent cites inquiries from U.S. authorities regarding its COVID-19 vaccine manufacturing [7/30/2021 12:55 PM] UPDATE 1-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant [Jul-29-21 12:25AM] REFILE-J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ [Jul-28-21 11:24PM] REFILE-UPDATE 1-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant [Jul-29-21 12:25AM] UPDATE 2-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant [Jul-29-21 12:25AM] Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility [Jul-29-21 07:25AM] UPDATE 3-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant [Jul-29-21 12:25AM] Sandy Hook families offered a settlement, J&J vaccine production resumes in Baltimore, AstraZeneca loses money on vaccine [Jul-29-21 11:01AM] Sandy Hook families offered $33 million, J&J vaccine production to resume in Baltimore, AstraZeneca loses money on vaccine [Jul-29-21 11:01AM] Emergent BioSolutions Stock Higher As COVID-19 Vaccine Production To Resume At Baltimore Plant [Jul-29-21 10:16AM] Emergent BioSolutions Reports Financial Results For Second Quarter 2021 [Jul-29-21 04:05PM] REFILE-UPDATE 3-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant [Jul-29-21 12:25AM] UPDATE 4-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant [Jul-29-21 06:30PM] Emergent Biosolutions (EBS) Lags Q2 Earnings and Revenue Estimates [Jul-29-21 07:25PM] Emergent BioSolutions inc (EBS) Q2 2021 Earnings Call Transcript [Jul-30-21 05:02AM] U.S. authorities probing Emergent BioSolutions over COVID-19 vaccine issues -filing [Jul-30-21 10:18AM] REFILE-U.S. authorities probing Emergent BioSolutions over COVID-19 vaccine issues -filing [Jul-30-21 10:04AM] UPDATE 1-U.S. authorities probing Emergent BioSolutions over COVID-19 vaccine issues- filing [Jul-30-21 10:42AM] U.S. authorities probing Emergent BioSolutions over COVID-19 vaccine issues - filing [Jul-30-21 10:18AM] Emergent (EBS) Misses on Q2 Earnings, to Restart Bayview Unit [Jul-30-21 09:54AM] UPDATE 2-US authorities probing Emergent BioSolutions over COVID-19 vaccine issues - filing [Jul-30-21 10:42AM] US authorities probing Emergent BioSolutions over COVID-19 vaccine issues - filing [Jul-30-21 10:18AM] EBS Long Term Investor Alert: Did You Acquire (EBS) Before April 24, 2020? - Contact Johnson Fistel Regarding Investigation [Jul-30-21 06:51PM]
29-04-2021	AH	4:05 PM ET (Apr 29)	EBS	Emergent Biosolutions, Inc.	3,430	1.53	0.97	0.01	Emergent Biosolutions EPS beats by $0.36, misses on revenue [4/29/2021 4:35 PM]	60.84	-2.31 (-3.66%)	61.50	-1.65 (-2.61%)	60.70 - 137.61	835,432	1,140,000	2,851
Emergent awaiting FDA OK to release 60M J&J vaccine doses - Bloomberg [4/29/2021 3:06 PM] Emergent Biosolutions EPS beats by $0.36, misses on revenue [4/29/2021 4:35 PM] CDC allocating J&J vaccine again, but still at low numbers [4/30/2021 12:46 PM] Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arcimoto, Emergent BioSolutions, and Verus International and Encourages Investors to Contact the Firm [Apr-28-21 09:00PM] SHAREHOLDER ALERT: MPLN KDMN EBS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines [Apr-28-21 05:20PM] Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. - EBS [Apr-28-21 04:00PM] SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS [Apr-28-21 03:08PM] HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact Its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEOs Insider Sales [Apr-28-21 02:25PM] EBS Stock: Berger Montague Investigates Potential Securities Fraud Claims Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021 [Apr-28-21 02:14PM] EBS INVESTOR ALERT: Shareholder Class Action Lawsuit Filed [Apr-28-21 01:00PM] EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc. [Apr-28-21 12:45PM] INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-28-21 11:02AM] EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Emergent BioSolutions Inc. Investors of Class Action and Encourages Investors to Contact the Firm [Apr-28-21 11:00AM] Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS) [Apr-28-21 11:00AM] Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE: EBS) [Apr-28-21 10:55AM] The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OTRK, LDOS and EBS [Apr-28-21 06:30AM] SHAREHOLDER ALERT: CLAIMSFILER REMINDS EBS, GOEV, RMO INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits [Apr-28-21 10:50PM] EBS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of Emergent BioSolutions Inc. [Apr-28-21 09:55PM] CLASS ACTION UPDATE for SOS, FGEN and EBS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Apr-29-21 06:30AM] EMERGENT SHAREHOLDERS: June 18, 2021 Filing Deadline in Class Action Contact Lieff Cabraser [Apr-29-21 09:01AM] The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLU, ATNX and EBS [Apr-29-21 10:25AM] EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Emergent BioSolutions Inc. Investors of Class Action and Encourages Investors to Contact the Firm [Apr-29-21 11:00AM] Emergent BioSolutions Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Deadline in Securities Fraud Class Action Lawsuit [Apr-29-21 11:11AM] INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-29-21 11:35AM] The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PLUG, RIDE and EBS [Apr-29-21 12:30PM] INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-29-21 01:15PM] Emergent BioSolutions Reports Financial Results for First Quarter 2021 [Apr-29-21 04:05PM] SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS [Apr-29-21 04:13PM] UPDATE 1-Emergent BioSolutions posts first-quarter profit on vaccine funding [Apr-29-21 04:55PM] Emergent BioSolutions posts first-quarter profit on vaccine funding [Apr-29-21 04:19PM] HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Fraud Class Action Filed, Application Deadline Established [Apr-29-21 05:03PM] Emergent Biosolutions (EBS) Q1 Earnings Top Estimates [Apr-29-21 05:45PM] UPDATE 2-Emergent hopes to answer U.S. FDA on Baltimore plant within days [Apr-29-21 04:55PM] Emergent hopes to answer U.S. FDA on Baltimore plant within days [Apr-29-21 04:19PM] EMERGENT BIOSOLUTIONS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Emergent BioSolutions Inc. - EBS [Apr-29-21 07:14PM] SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-30-21 12:50AM] ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - EBS [Apr-29-21 11:02PM] Emergent BioSolutions Inc (EBS) Q1 2021 Earnings Call Transcript [Apr-30-21 05:31AM] The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PLUG, EBON and EBS [Apr-30-21 06:30AM] EMERGENT INVESTORS: June 18, 2021 Filing Deadline in Class Action Contact Lieff Cabraser [Apr-30-21 09:00AM] New Strong Sell Stocks for April 30th [Apr-30-21 09:19AM] CLASS ACTION UPDATE for RIDE, FGEN and EBS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Apr-30-21 10:05AM] Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE:EBS) [Apr-30-21 10:45AM] Emergent (EBS) Beats on Q1 Earnings, Cuts Contract Revenue View [Apr-30-21 10:06AM] DEADLINE ALERT for FUV, EBS, and ACAD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders [Apr-30-21 11:00AM] EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Emergent BioSolutions Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm [Apr-30-21 11:00AM] SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-30-21 11:40AM] Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS) [Apr-30-21 12:30PM] LAWSUITS FILED AGAINST FGEN, CAN and EBS - Jakubowitz Law Pursues Shareholders Claims [Apr-30-21 12:45PM] Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (EBS) [Apr-30-21 02:03PM] Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days [Apr-30-21 11:14AM] The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VLDR, REGI and EBS [Apr-30-21 02:30PM] ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline EBS [Apr-30-21 07:36PM] HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Class Action Filed, Application Deadline Approaching [Apr-30-21 07:00PM] Emergent BioSolutions Inc. -- Moody's affirms Emergent's Ba2 CFR; revises outlook to negative [Apr-30-21 05:55PM] Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg [Apr-30-21 02:35PM] Canada to not distribute JNJ COVID-19 vaccines until quality checks complete [Apr-30-21 08:01PM] UPDATE 1-Canada receives J&J's COVID-19 vaccine from plant where FDA halted production [Apr-30-21 08:20PM]
18-02-2021	AH	4:05 PM ET (Feb 18)	EBS	Emergent Biosolutions, Inc.	6,630	3.67	2.72	1.57	Emergent Biosolutions EPS beats by $0.26, beats on revenue [2/18/2021 4:28 PM]	102.94	-14.12 (-12.07%)	111.27	-5.79 (-4.95%)	46.37 - 137.61	1,980,724	440,707	4,959
Emergent Biosolutions EPS beats by $0.26, beats on revenue [2/18/2021 4:28 PM] Emergent Bio cut to neutral at Chardan on valuation [2/19/2021 3:25 PM] Looking Into Emergent BioSolutions's Return On Capital Employed [Feb-19-21 10:57AM] Emergent BioSolutions Inc (EBS) Q4 2020 Earnings Call Transcript [Feb-19-21 04:01AM] UPDATE 3-Vaccine manufacturing deals power Emergent BioSolutions profit beat [Feb-18-21 04:25PM] Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020 [Feb-18-21 04:05PM] Emergent BioSolutions, Inc. to Host Earnings Call [Feb-18-21 03:15PM]
05-11-2020	AH	4:25 PM ET (Nov 5)	EBS	Emergent Biosolutions, Inc.	4,910	2.19	2.05	1.21	Emergent Biosolutions EPS beats by $0.04, misses on revenue, revised FY20 guidance [11/5/2020 5:40 PM]	92.04	-4.96 (-5.11%)	93.35	-3.65 (-3.76%)	46.37 - 137.61	685,634	484,972	4,178

30-07-2020	AH	4:10 PM ET (Jul 30)	EBS	Emergent Biosolutions, Inc.	4,850	1.98	0.53	0.12	Emergent Biosolutions beats on revenue [7/30/2020 4:39 PM]	110.21	13.19 (13.60%)	104.03	7.01 (7.23%)	39.11 - 114.13	1,053,110	1,945,492	4,523